Assessment of Depression and Anxiety Among Admitted People With Heart Disease Conditions: A Cross-Sectional Hospital-Based Study in a Bangladeshi Population During the COVID-19

Abstract

ObjectiveDepression and anxiety are widespread and chronic among patients with heart disease. We wanted to determine the proportion of heart patients with depression and anxiety levels as well as factors contributing toward depression and anxiety among hospitalized heart disease patients in Dhaka, Bangladesh during the COVID-19 era.MethodsThe study comprised a total of 384 participants with a confirmed heart disease diagnosis. We conducted a cross-sectional study from 5th March to 27th June 2021. The hospital-based study admitted patients sequentially with a new or pre-existing heart disease diagnosis to one of Dhaka's two leading hospitals. The Hospital Anxiety and Depression Scale screened all individuals for depression and anxiety.ResultMost of the respondents (88.2%) were male and within the age categories of 51–60 years (32.81%). 96.6% of the patients were married, 30% had no income, 36.6% had only completed classes 1–5, and ~47% resided in rural areas. Approximately 36% of the study participants were former smokers, with 31% current smokers. Borderline abnormal and abnormal levels of anxiety and borderline abnormal and abnormal levels of depression were found in (23.9%, 49.4%) and (55.7%, 13.3%), respectively, of hospitalized patients. Age, residence, profession, monthly income, and chronic disease were significant predictors of anxiety, while only gender remained significantly associated with depression.ConclusionHospitalized Bangladeshi patients with heart disease had moderate levels of depression and anxiety. There is a need to develop a quick screening approach in hospitals dealing with hospitalized patients with heart disease to identify those needing extra evaluation and care.

Depression and anxiety among patients with cardiovascular disease in a tertiary care centre

“…5 Amin et al in their respective study also found significant association between the use of smoking followed by alcohol for the development of cardiovascular diseases and psychiatric illness. 12 This finding was also evidenced by Jha et al in their respectful study. 4 This study found that smoking was prevalent in 76.25% of CVD patients, while alcohol abuse was identified in 73.75%.…”

Prevalence and risk factors for anxiety and depression among community dwelling patients with cervical spondylosis during the COVID-19 pandemic

“…Our present study was conducted in the context of the post-pandemic ages of COVID-19, when urgent and large-scale infectious events have been well contained in China. In contrast, the impact of pandemic crisis and corresponding normalized prevention and control measures, such as social distancing and activity restriction created an unpleasant atmosphere of vigilance and alarm and caused uncertainty, social isolation and loneness, and financial loss, thereby potentially triggering a range of negative emotional responses in the general population and patients with COVID-19 and/or other chronic conditions, including anxiety and depression [ [41] , [42] , [43] ]. This might explained the significant but weak-to-moderate association between fear and anxiety/depression among community dwelling CS patients.…”

The mediating role of cardiac patients’ perception of nursing care on the relationship between kinesiophobia, anxiety and depression in rural hospitals: a cross-sectional study

“…Each question is scored on a scale from zero (indicating no impairment) to three (indicating severe impairment), resulting in a maximum score of 21 for both anxiety and depression [ 37 ]. The HADS has been widely used to assess anxiety and depression in cardiac patients, and a study by Amin et al (2022) [ 38 ] reported a Cronbach’s alpha value of 0.70, indicating good internal consistency. To aid in the interpretation of scores, a classification scheme can be applied: scores ranging from 0 to 7 suggest the absence of clinical symptoms, scores between 8 and 10 indicate moderate levels of depression or anxiety, and scores from 11 to 21 indicate the presence of clinically significant depression or anxiety.…”